Proud to see Metabolon colleagues Dr. Adam Kennedy & Dr. Greg Michelotti leading a new Metabolites Special Issue: https://bit.ly/4sIFZyu
“Advances in Metabolomics for Precision Medicine” explores earlier disease detection, new biomarkers, and improved tracking of therapeutic response.
Reliability is often overlooked in LC-MS, but it shouldn’t be.
At Metabolon, a systems-level approach to QC, harmonization, and maintenance reduces rework to ~3% and protects uptime.
Operational excellence = better data, better outcomes.
🔗 Read more: https://bit.ly/4tKKaum
What turns insight into impact?
Michael Irwin, our VP of Sales, shares why belief + disciplined execution drive real results.
At Metabolon, that’s how we’re advancing metabolomics in the multiomics landscape.
Read more: https://bit.ly/4bYAfeH
Live from #ADPD2026
Advancing Parkinson’s research by capturing real-time biochemical changes, in collaboration with @MichaelJFoxOrg.
Come by booth #01C to learn more!
We are thrilled to join the #EPILifestyle26 conference in Boston this week and discuss how to leverage metabolomic analysis to dissect cardiometabolic risk in large-scale population studies.
Meet Tony di Meco and Katherine Black at booth #6 between March 17th and 20th!
We’re proud to announce our collaboration with The Michael J. Fox Foundation to advance multiomic analyses and biomarker discovery in Parkinson’s research, a disease where diagnosis and treatment remain challenging despite its prevalence.
🔗https://mtbln.co/fq53ts
Heading to #ADPD2026? Stop by booth #01C to see how metabolomics is advancing neuroscience research.
🔬 Reveal early disease biology
🧠 Discover biomarkers across 5,400+ metabolites
📊 Turn data into biological insight
📅 Mar 17–21
🤝 Book a meeting: mtbln.co/ugw7l7
How can metabolomics move beyond traditional biomarkers to better understand human health?
Our Head of R&D, Dr. Annie Evans, explains: mtbln.co/y5rly8
Leadership shaped by diverse perspectives drives scientific progress. Supporting women in science matters.
#InternationalWomensDay
In a new interview, Dr. Heino Heyman, shares how metabolomics helped uncover metabolic signatures linked to neurological events in patients treated with CAR-T therapies. 🔗 lnkd.in/ezrSdvXr
Do you want to implement metabolomics in your drug development workflows? Watch: mtbln.co/3gavtd
What if inflammatory cytokines aren’t the best predictors of CAR-T neurotoxicity?
Across 3,800+ samples from six trials, metabolomics revealed pathway-level disruptions that outperformed IL-6 and TNFα in predicting severe events. Disease progression shared metabolic drivers.
More: mtbln.co/azc4kw
On #InternationalWomenAndGirlsInScienceDay, we celebrate the incredible women scientists at Metabolon.
Special congratulations to Dr. Annie Evans and Dr. Natasa Giallourou, featured by @metabolomicsj.bsky.social for their outstanding contributions to the field.
Proud to work alongside you. 🧪💜
Read more about this announcement in the press release: mtbln.co/d3kucj
A new metabolite has joined the team!
Help us welcome Andrew Messick, our new Chief Financial Officer.
Drew brings more than 25 years of financial leadership experience in the life sciences and will be instrumental as we continue to scale and advance our strategic growth initiatives.
Contact us today to learn more: mtbln.co/nzzd43
@metabolomicsj.bsky.social
Can dried blood spots (DBS) support scalable, minimally invasive, remote studies?
A new study in @metabolomicsj.bsky.social shows that DBS capture exercise-induced metabolic changes across broad pathway coverage using Metabolon's platform.
Episode 5 is live! Molecules to Medicine — Dosing & Timing
In this episode, Dr. Natasa Giallourou explores how pharmacometabolomics can refine both dose and timing, using a busulfan/HSCT case study to demonstrate its advantages over traditional PK/PD approaches.
Watch here: mtbln.co/lahkjb
Molecules to Medicine Episode 4 is live! Safety & Toxicity
Safety failures are a major cause of drug attrition. Learn more about a CAR-T case study showing how metabolomics revealed the biochemical drivers of toxicity, helping a safer and more effective use of this therapy. mtbln.co/9bczl8
Molecules to Medicine - Episode 3: Translatability
How well do findings in non-human models translate to humans? Dr. Heino Heyman shows how metabolomics confirms conserved biochemical pathways across multiple Batten’s Disease models, boosting confidence in the next steps.
👉https://mtbln.co/2idajz
New Webinar Series: 💊 Molecules to Medicine⚕️
Learn how metabolomics drives decisions across the drug development pipeline, from target ID to safety, dosing & patient stratification.
📺 Watch Ep1 on how metabolomics was applied to identify candidate drug targets for (IBD): mtbln.co/sfqmwo
How do lifelong environmental exposures shape health?
Our eBook, Guide to the Exposome, explores how metabolomics is unlocking this complexity, advancing research, public health, and precision medicine.
Download your copy: mtbln.co/xeokxe
Continuous improvement drives us at Metabolon.
Our recent Kaizen workshop transformed the quoting process, modernizing workflows, boosting accuracy, and accelerating customer experience. A culture of excellence, built for scale.
Read more about our recent Kaizen workshop:
Pharma companies take note - human knockouts in bottleneck and consanguineous populations are up and coming.
Plasma Metabolic Outliers Identified in #Estonian Human Knockouts: www.mdpi.com/2218-1989/15...
citing our #Qatar study with @metabolon.bsky.social data:
www.cell.com/cell-genomic...
Unlock functional biology with metabolomics!
Join our webinar to see how integrating metabolomics into multiomics reveals hidden pathways & drives biological insight.
Discover DIABLO & PathIntegrate in action through real case studies.
Register today!
buff.ly/AtD7tti
From data to destiny: reproducible #metabolomics is the foundation of a connected multiomics future.
When metabolomics meets genomics, proteomics & transcriptomics, discovery moves from possibility to proof.
Read more in our latest blog:
Metabolomics isn’t just transforming human health; it’s helping our pets live healthier, longer lives.
A new study from The Farmer’s Dog, supported by Metabolon, shows how fresh, human-grade diets drive metabolic changes linked to healthy aging.
Learn more: buff.ly/FcAokL4
Metabolon at #ELRIGDrugDiscovery2025!
Don't miss our poster "Integrative Multiomics: Bridging Metabolomics & Proteomics for Systems-Level Insights".
Discover how Metabolon’s platform helps translate complex data into actionable insights for drug discovery!
#DD25
At #ASHG25?
We are too!
Come by booth #1160 to know more about how the combination of genomics with metabolomics can transform raw data into precise biomarkers and biological insights.
Metabolon has now been cited in 4,000+ peer-reviewed publications—more than any other provider in the industry.
It’s more than a number: it shows the trust scientists have in our work and the critical role of metabolomics in multi-omics research.
Here’s to the next 4k citations!
